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Cancer stem cells, also known as tumour-initiating cells (TICs), are identiﬁed as highly tumorigenic
population within tumours and hypothesized to be main regulators in tumour growth, metastasis
and relapse. Evidence also suggests that a tumour microenvironment plays a critical role in the
development and progression of cancer, by constantly modulating cell–matrix interactions.
Scientists have tried to characterize and identify the TIC population but the actual combination of
extracellular components in deciphering the fate of TICs has not been explored. The basic
unanswered question is the phenotypic stability of this TIC population in a tissue extracellular
matrix setting. The in vivo complexity makes it diﬃcult to identify parameters in a diverse milieu
that aﬀect TICs behaviour. Herein we studied how the TIC population would respond when
subjected to a unique microenvironment composed of diﬀerent extracellular proteins. The
TIC-enriched population isolated from a Her2/neu-induced mouse mammary tumour was cultured
on collagen, ﬁbronectin and laminin coated substrates for one to two weeks. Our observations
indicate that a laminin substrate can maintain the majority of the self-renewing and tumorigenic
TIC population, whereas collagen induced a more diﬀerentiated phenotype of the cells. Also
interestingly, ﬁbronectin substrates dictated an invasive phenotype of TICs as evidenced from the
EMT-related gene expression pattern. The results of this study signify that the microenvironmental
cues play a considerable role in tumour relapse and progression by altering the cancer stem cell
behaviour and thus this knowledge could be used to design novel cancer therapeutics.
Introduction
Cancer Stem Cells (CSCs), also known as tumour-initiating
cells (TICs), are a highly tumorigenic population that exist as a
subset within tumours and have been hypothesized to be
main regulators in tumour growth, metastasis, and relapse.1–3
Characterizing their phenotype and analyzing the underlying
mechanism that confers to their tumour initiating properties
have signiﬁcance in the ﬁeld of cancer biology.4 The isolation
of CSCs has been reported from various human solid tumours
like breast, colon and brain tumours.5 Although the origin of
CSCs is not clearly understood, it has been shown to share
several cell surface markers and molecular signatures with
normal embryonic and adult stem cells, together with self-
renewing potency and diﬀerentiation ability.6
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Insight, innovation, integration
Cancer Stem Cells (CSCs) are identiﬁed as highly tumori-
genic population within tumours and considered regulators
in tumour growth, metastasis and relapse. Evidence also
suggests that a tumour microenvironment plays a critical
role in the cancer progression, by constantly modulating cell-
matrix interactions. The basic unanswered question is the
phenotypic stability of this CSCs population in tissue
extracellular matrix setting. The in vivo complexity makes
it diﬃcult to identify parameters in a diverse milieu that
aﬀect CSCs behaviour. In this paper we have utilized 2D
ECM coatings to evaluate CSCs response combined with
biological analysis of the functional properties of these cells.
This paper provides a better understanding of the cell–substrate
interactions taking place in a tumor microenvironment and
thus this knowledge has implications in designing novel
biomaterials for developing cancer therapeutics.
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Adult stem cells sustain a balance between self-renewal
and diﬀerentiation, which is critical for maintaining tissue
homeostasis. In 1978 Schoﬁeld proposed the existence of a
‘‘niche’’ or a specialized compartment in hematopoietic stem
cells that might provide a physiological microenvironment to
create a balance between these two key processes. The niche
composed of supportive cells and ECM probably regulates
stem cell fate by an interacting mechanism which involves
creating cytokines gradient, matrix stiﬀness and the presence
of immobilized signalling molecules.7 After knowing the vital
role played by the normal stem cell niche in maintaining stem
cell fate, it is logical to assume the existence of a ‘‘CSC niche’’ or
tumour niche which can similarly regulate CSCs behaviours.
In breast cancer one of the most important questions yet to be
answered is whether breast CSCs originate from normal mammary
stem cells.8 It can be assumed that both breast CSCs and normal
mammary stem cells may reside in a special compartment
adjacent to fully diﬀerentiated cells but maintain their progenitor
status. Little is known, however, about the speciﬁc ECM cues
that interact with the cells to either retain quiescence or drive the
cells to a deﬁnite course.9 The major structural protein in the
mammary gland is ﬁbrillar collagen, which is in close contact
with a highly organized and specialized ECM region named the
basal lamina that in turn separates the epithelium from the
underlying stroma.10 The proteins comprising the basal lamina
were classically identiﬁed as collagen IV, laminins, entactins and
proteoglycans. Tumour stroma undergoes remodelling during
carcinogenesis and also sometimes prior to tumour formation by
allowing deposition of collagen I in a random orientation with
other ECM proteins like ﬁbronectin.11 These ECM proteins bind
to speciﬁc cell surface receptors known as integrin proteins and
can induce integrin signalling. Several integrin proteins have
been shown to be over-expressed in CSCs, which signiﬁes that
receptors of these integrins are present in the surrounding
matrix and are key drivers of the CSC fate.
Scientists have tried to characterize and identify the CSCs
population but the actual combination of extracellular com-
ponents in deciphering the CSCs fate has not been explored.
The basic unanswered question so far has been the phenotypic
stability of this tumour initiating population of cells in a tissue
microenvironment. It will be very important to address the
functional properties and gene expression proﬁle of these cells to
predict their fate. If we can identify cues from amicroenvironment
that regulates CSCs activity in vitro, it would have important
implications in designing suitable ex vivo model systems to study
these cells and in designing proper therapeutic targets.
Recently in our lab we identiﬁed a TIC population in a
Her2/neu-induced mammary tumour that was characterized by
enhanced expression of CD49f and CD61 integrin markers.12
This enriched population demonstrated higher in vitro tumor-
sphere formation, clonogenicity and in vivo tumorigenicity,
keeping with the CSC hypothesis.12 In this paper we report
the study of using this TIC model to explore its responses to
various extracellular matrix components like collagen-I (Coll-I),
ﬁbronectin (Fn) and laminin-I (Lam-I). The inherent charac-
teristics of these cells to undergo diﬀerentiation and self-
renewal under the inﬂuence of diﬀerent ECM proteins were
evaluated. The results of this study indicate that the micro-
environmental cues from the ECM play a signiﬁcant role in
tumour progression and development and can be a novel
target for designing cancer treatment.
Results
We previously reported that Her2/neu-induced mouse mammary
tumour cells can be enriched for TICs by sorting using a combined
expression of integrin markers CD49f and CD61.12 H6O5 cells
were subjected to FACS sorting and CD49fhighCD61high
population of cells characterized previously with higher
stem/progenitor phenotype and enhanced tumorigenicity12
were isolated and cultured on ECM coated substrates
(Fig. 1a). Sorted cells were immediately seeded on Coll-I, Fn
and Lam-I substrates keeping TCP as a control and cultured
for 1 to 2 weeks. As seen from phase contrast micrographs
(Fig. 1b), sorted H6O5 cells propagated on Coll-I and Fn in a
well-spread adherent monolayer similar to the TCP control. In
comparison, sorted H6O5 cells exhibited a more clustered
morphology on Lam-I, with adherent islands of cells clumped
together. Cells were passaged and maintained on the coated
substrates every 2–3 days up to 2 weeks. Similar cell morphology
on each ECM coated matrix was observed with each sub-
culturing and propagation till 2 weeks. Trypsinization of cells
during passaging on Coll-I, Fn and TCP required 10 minutes
at 37 1C whereas only required 5 minutes for Lam-I matrices.
As a control study we also tested the morphology of H6O5
cells on poly-D-lysine coated TCP and uncoated TCP. No
diﬀerence in morphology was observed and cells grew and
propagated normally (Fig. S1, ESIw).
The impact of ECM proteins on the maintenance of the
TICs population was examined by monitoring the signature
integrin expression proﬁle. FACS sorted tumour initiating
H6O5 cells were cultured on Coll-I, Fn, Lam-I and TCP
control, respectively, for 1 to 2 weeks; and at the end of each
week ﬂow cytometry studies were conducted to evaluate the
expression levels of CD49f and CD61 markers. As shown in
Fig. 2, the percentage of the CD49fhighCD61high population
after week 1 was signiﬁcantly higher in sorted H6O5 cells
cultured on Lam-I coated substrates (49.9%) followed by Fn
coated substrates (34.4%). In contrast, the percentage of the
double positive population signiﬁcantly decreased in cells
cultured on Coll-I (15.5%), whereas the TCP control cells still
retained 21.4% of this cell subset. Flow cytometry study
conducted after two-week culture on the ECM coated sub-
strates further substantiates that Lam-I maintained the highest
of the double positive (49.1%) cell pools in comparison to
Fn (31.9%), Coll-I (16.77%) and the TCP control (21.9%)
(Fig. S2, ESIw). Our previous ﬁndings report that the percen-
tage of CD49fhighCD61high subset reﬂects the TICs population
in a Her-2/neu induced mouse mammary tumor.12 Therefore
this result indicates that Lam-I can maintain the majority of
the TIC population whereas Coll-I shows signiﬁcant loss.
To conﬁrm that the maintenance of CD49fhighCD61high-
expressing H6O5 cells in the ECM coated substrates also
correlates with the functional aspects of the TIC population,
in vitro tumorigenic and clonogenic assays were conducted.
In vitro tumorigenicity was assessed by tumorsphere formation
in suspension culture which is also a characteristic hallmark
to identify the self-renewal properties of cancer stem cells.13
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In suspension culture, H6O5 cells from Lam-I coated matrices
showed the highest (1.36  0.05%) tumorsphere formation
eﬃciency after week 1 analysis. Sphere forming eﬃciency of
H6O5 cells on Lam-I was signiﬁcantly higher (p o 0.05) in
comparison to Fn (0.60  0.09%), Coll-I (0.50  0.10%) and
the TCP control (0.43 0.07%) (Fig. 3a and b). Eﬃciency was
Fig. 1 (a) FACS isolation of TIC population from Her2/neu-induced primary mammary tumour H6O5 using the expression proﬁle of
CD49fhighCD61high, the gated cell subset (B15%) was cultured on ECM coated substrates. (b) Phase contrast micrographs of the isolated
TIC-enriched population on Coll-I, Fn, Lam-I substrates and TCP control after one week of culture. Scale bar = 50 mm.
Fig. 2 FACS analysis showed that Lam-I and Fn maintained the majority of the TIC population whereas Coll-I and TCP cell cultures exhibited
signiﬁcant loss of TICs after one week of culture on coated substrates. The FACS analysis data were also plotted as a bar graph (the bottom panel).
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not considerably diﬀerent between Coll-I and Fn substrates
but showed statistical diﬀerence between Fn and TCP control
substrates, the former being higher (p o 0.05). Very similar
results were obtained after week 2 culture on ECM coated
matrices where Lam-I showed signiﬁcantly higher eﬃciency
(1.47  0.07%) with respect to Fn (0.71  0.03%), Coll-I
(0.57  0.01%) and the TCP control (0.44  0.06%) (Fig. S3a
and b, ESIw).
Clonogenic potential is a common assay used to quantify
the number of TICs in a heterogeneous sample. It is the ability
of a single cell to generate daughter cells of its own kind and
also adds to the degree of tumorigenicity and also an intrinsic
property of adult stem cells.14 The TIC-enriched cell popula-
tion of H6O5 cells cultured on various ECM matrices was
tested for clonogenic potential in a limiting dilution fashion.
It was observed that H6O5 cells retrieved from Lam-I coated
matrices showed the highest numbers of colony in comparison
to Coll-I, Fn and control TCP (Fig. 3c and d). Although
signiﬁcant diﬀerence is obtained between Lam-I, Coll-I and
TCP control, no statistical diﬀerence was observed between
Lam-I and Fn. However, 25% of the colonies from Lam-I was
greater than 2 mm than those from the rest of the ECM
proteins. Interestingly the colony forming ability decreased
from Lam-I > Fn > TCP > Coll-I. Results from week 2
culture indicated similar phenomena (Fig. S3c and d, ESIw),
where cells from Lam-I showed signiﬁcantly higher clonogeni-
city in contrast to Coll-I, Fn and TCP control. Our data
signify that TICs maintained their highest self-renewing ability
and tumorigenic potential in Lam-I coated substrates in
contrast to Fn, Coll-I and TCP (Fig. 3b).
To evaluate the inﬂuence of diﬀerent ECM proteins on the
gene expression of TICs, quantitative reverse transcriptase
PCR analysis was performed to examine the expression of
stem cells, diﬀerentiation and epithelial-to-mesenchymal tran-
sition (EMT) related genes. The expression of diﬀerentiation
markers like Krt18 and Krt14 was signiﬁcantly up-regulated in
the cells cultured on Coll-I, in comparison to Fn, Lam-I and
TCP (Fig. 4a). Expression analysis of cancer stem cell markers
showed that Aldh1,15 CD13316 and Abcg217 expression levels
were highest in cells cultured on Lam-I whereas the expression
of diﬀerentiation markers in the Lam-I culture did not show
signiﬁcant diﬀerence to the TCP control. Interestingly, Gli1,
a stem cell marker,18 was also expressed equally in Lam-I and
Fn cultures, and the expression of Aldh1 in Fn cultures was
signiﬁcantly higher than both Coll-I and TCP cultures
(Fig. 4b). The observations of up-regulation of diﬀerentiation
marker genes and down-regulation of stem cell marker genes
in the Coll-I culture indicate a diﬀerentiation phenotype of
H6O5, whereas gene expression analysis of the Lam-I culture
indicates a putative stem-cell-like phenotype in comparison to
those cultured on other substrates (Fig. 4b). The enhanced
expression of certain stem-cell-related genes in Fn and Lam-I
cultures further triggered us to analyze the expression of
EMT-related genes in these cells. We observed that genes like
Snail, Twist, Zeb1, and Cdh2 were highly expressed in the Fn
culture with respect to the TCP control, which are well known
EMT inducers (Fig. 4c). The EMT like phenotype has been
reported to be the traits of CSCs that are induced by the
TGF-b signaling.19 Keeping this in mind we also tested several
TGF-b responsive genes like Foxc2,20 Il621 and Pai22 (Fig. 4d).
Fig. 3 TICs exhibit greatest self-renewal characteristics in Lam-I after one week of culture. (a) In vitro tumorsphere formation analysis of TICs
retrieved from Coll-I, Fn, Lam-I and TCP. Scale bar = 50 mm. (b) Plot showing sphere formation eﬃciency (SFE) for each substrate. (c) In vitro
clonogenic assay of TICs pre-cultured on Coll-I, Fn, Lam-I and TCP substrates. (d) Plot showing colony numbers for each substrate. All
measurements were performed in triplicates and data are indicated as mean  standard deviation. (*) po 0.05 indicates a statistically signiﬁcant
diﬀerence.
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Two of these genes (Il6 and Pai) were observed to be up-regulated
in the Fn culture, suggesting that an EMT like phenotype was
induced in the Fn culture. Together, we have demonstrated
that TICs acquire a diﬀerentiation phenotype on Coll-I sub-
strates, whereas they retain majorly stem-cell traits on Lam-I.
Considerable increase in the EMT-related genes clearly shows
an attainment of invasive phenotype by the TICs when
cultured on Fn coated substrates.
Discussion
Recent evidences from the literature validate ECM not only as a
mere physical scaﬀold but also as an inﬂuential regulator in cell
behaviour. A bidirectional crosstalk exists between the cell and its
immediate surrounding ECM, whether secreted endogenously or
supplied from outside, where the ECM inﬂuences gene expression
and the cell, in turn, can remodel the ECM, which then further
acts on the cell creating a feedback loop.23 The cell senses this
ECM structure with the help of a family of heterodimeric
transmembrane proteins called integrins, which can direct ECM
derived signals to the cell and give rise to cell-speciﬁc functions.
These phenomena have been accomplished in the mammary
gland both during morphogenesis and tumorigenesis.
Data suggest that type-I collagen mediates ductal morpho-
genesis, and collagen derived signals are critical for primary
branching and for basement membrane production during
mammary gland development.24 Extracellular protein laminin-I
signalling is also crucial during lactation and for inducing tissue
speciﬁc function in the mammary gland.25 Also, mammary
epithelial speciﬁc stem cells exist throughout the gland’s lifetime
and reside in a unique niche in the terminal ducts next to
diﬀerentiated cells. Not much work has been done to evaluate
the role of ECM in this niche which modulates cell–ECM
interaction in maintaining quiescence or diﬀerentiation in a
particular lineage. CSCs (or TICs) may also reside in such
microenvironment in contact with fully diﬀerentiated cells, but
yet maintains their progenitor phenotype. During tumorigenesis
restructuring of the ECM takes place, allowing deposition of a
large amount of collagen-I, enhanced ﬁbronectin accumulation
and loss of laminin signalling which stimulates formation of
Fig. 4 Quantitative real-time reverse transcription PCR analysis of gene expression in Coll-I Fn and Lam-I cultures compared to the TCP
control: (a) diﬀerentiation markers, (b) stem cell markers, (c) EMT markers and (d) TGF-b downstream genes associated with EMT. Each
expression was normalized using Gapdh as the internal control. (*) p o 0.05 obtained from the ‘pair wise ﬁxed reallocation randomization test’
represents signiﬁcant diﬀerence between cells on coated substrates and TCP control.
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a reactive environment.26–28 Failure of the cells to systematically
interpret compositional alterations in the surrounding ECM gives
rise to malignant transformation. In our work we isolated the TIC
population from a Her2/neu-induced mouse mammary tumour
using an expression using two integrins markers CD61 (b3) and
CD49f (a6) to address how TICs respond to diﬀerent extracellular
cues provided by the extracellular matrix proteins present in the
immediate tumour surrounding and determine its fate.
Coll-I and Fn promoted adhesion of the sorted TICs in a
monolayer whereas Lam-I inhibited growth in a monolayer and
forced the cells to form a clustered structure. Detachment of cells
with trypsin from Lam-I substrates took only 5 minutes while it
took almost 10 minutes on other substrates, suggesting cells on
Lam-I were loosely attached in comparison to other ECM
proteins. The reduced adhesion of breast cancer cells to Lam-I
has been previously reported in MCF-7 cells.29 It was observed
that the sorted cells on Coll-I, Fn and TCP showed proliferation
rate twice as much to Lam-I. This also suggests that Lam-I
maintains the TICs in a slower proliferating state. Similar
observation was obtained previously from the study of mammary
stem cells in a laminin rich environment.30,31 Although decreased
adhesion was observed in Lam-I, interestingly this substrate
maintained the majority of the TIC population of Her2-
overexpressing breast tumour cells. The percentage of the
CD49fhighCD61high cell population in sorted cells cultured on
Lam-I coated substrates for 1 week was 49.9%, which was
maintained till 2 weeks (49.1%) of culture. This can be partially
attributed to the lower adhesion and proliferation of the cells in
Lam-I substrates as the literature reports that stem cells are known
to remain in a more quiescent state and hence maintain their self-
renewal characteristics.30 The maintenance of stemness in the
Lam-I substrates has been conﬁrmed by the enhanced clonogenic
potential and tumorsphere formation ability of these cells.
Cells from Lam-I substrates not only gave rise to more
number of colonies but also showed colonies with larger
dimensions in comparison to those on other ECM proteins.
Gene expression proﬁling results also showed that cells from
Lam-I cultures displayed higher expression of stemness related
genes like Abcg2, CD133, Gli1 and Aldh1. Microenvironmental
cues are transmitted from the matrix to the cell via integrins
which undergo allosteric changes triggering cell signalling
pathways.32 Laminin signalling has been shown to be impor-
tant in mammary gland development and tumorigenesis.9 In
this respect a6b1 is the most studied integrin.33 In our study we
have observed the signiﬁcant up-regulation in mRNA expres-
sion of CD49f (a6), b1, av and CD61 (b3) in the Lam-I culture
compared to the control TCP (Fig. S4, ESIw). Although the
a6b1 dimeric complex has been well known in laminin inter-
action, avb3 interaction to laminin was demonstrated in human
vascular endothelial cells.34 This indicates that interaction
between these integrins might play a critical role in integrin-
mediated laminin signalling. The enhanced tumorigenic pro-
perty of the TICs in Lam-I and stemness maintenance could be
accounted by the interaction of Lam-I with b3 integrin.
The TIC population on Fn showed similar attachment and
proliferation as the control TCP culture. Interestingly the
percentage of the CD49fhighCD61high cell population after 1 week
of culture was 16% higher than that from the TCP culture which
was maintained till week 2. Also, clonogenic potential was
signiﬁcantly higher in the Fn culture in comparison to the TCP
control, but no signiﬁcant increment was observed in tumor-
sphere formation after week 1. Gene expression analysis of
mRNA levels of Gli1 and Aldh1 suggests that a considerable
amount of the TIC population is still retained by the Fn
substrates. Role of ﬁbronectin in mammary gland development
is not widely studied but ﬁbronectin deposition has been observed
in breast cancer development and tumour invasion. Our study
also reveals that TICs in an Fn-rich environment showed
enhanced expression of Zeb1, a transcriptional protein associated
with breast cancer metastasis,35 and minor upregulation of Snail
and Cdh2. As cancer metastasis is said to occur by an epithelial-
to-mesenchymal transition and TGF-b is also an eﬀective inducer
of EMT,36 we studied several downstream genes of the TGF-b
signalling pathways. The enhanced expression of Pai and Il6
suggests that the Fn scaﬀold promotes an EMT-like transition
through the TGF-b mediated pathway. This observation can be
further explained by the enhanced expression in mRNA levels of
a5 and b1 integrins in sorted cells cultured in the Fn substrates
(Fig. S4, ESIw). The literature reports that these integrins, identi-
ﬁed as major receptors of ﬁbronectin may interact with the
TGF-b Receptor-II and play a major role in EMT induction.37
Coll-I substrates showed the minimum retention of the TIC
population after one week of culture compared to the other
ECM proteins. Clonogenic and mammosphere formation
studies revealed that the cells on the Coll-I culture signiﬁcantly
lost their tumorigenic potential. Apart from Aldh1 expression all
the other stem cell markers were shown to be down-regulated in
the Coll-I substrates. On the other hand up-regulation of diﬀer-
entiation markers, Krt18 and Krt14, suggests that cells are under-
going a diﬀerentiation phenotype in Coll-I substrates. Literature
reports supported that collagen-I substrates can induce diﬀeren-
tiation in mammary progenitor cells D290 in vitro cultures and
regulate expression of Krt14 and Krt18 drastically.30 In vitro
tumorigenic assays also signify loss in stemness accompanied
with enhanced diﬀerentiation on the collagen scaﬀold, yet no
signiﬁcant increase in a1, a2 and b1 integrins was observed in
mRNA expression levels (Fig. S4, ESIw).
Experimental
Cell isolation and culture
H6O5 cells were isolated from a primary mammary tumor
using the protocol previously described38 and maintained in
DMEM/F12 (Invitrogen, CA, USA), supplemented with 2 mM
L-glutamine and 10 mg per mL of insulin (Sigma) in a 5% CO2
humidiﬁed incubator at 37 1C. H6O5 was enriched for
CD49fhighCD61high subpopulation using ﬂuorescence assisted
cell sorting (FACS, Fig. 1a). Sorted cells were immediately
seeded on Coll-I, Fn, TCP at a density of 50 K cells per cm2 and
at 100 K cells per cm2 for Lam-I. Cells were maintained in ECM
coated plates for one to two weeks and analyzed.
Preparation of ECM coated substrates
Collagen-I (rat tail) and ﬁbronectin (human) were coated on
tissue culture polystyrene at a concentration of 0.1 mg mL1 and
20 mg mL1, respectively, for 1 h at 37 1C. All ECM proteins were
obtained from BD biosciences. Laminin-I (mouse) (20 mg mL1)
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was coated on a poly-D-lysine (Mw = 500–550 kDa, BD
Biosciences) precoated Tissue Culture Plastic (TCP) for 1 h at
37 1C, rinsed with deionized H2O, air dried in a laminar ﬂow
hood and stored at 4 1C prior to cell seeding. Homogeneity and
uniform coating for each ECM proteins were conﬁrmed using
water contact angle measurements taken from random area for
n= 5 and indicated as average in Table S1 (ESIw). Using poly-
D-lysine is a standard practice and has been extensively used to
facilitate adhesion of bioactive molecules for cell culture.39,40 As
a control study we also tested the morphology of H6O5 cells and
MCF-7 cells on poly-D-lysine coated TCP and uncoated TCP.
Flow cytometry analysis and sorting
Flow cytometry was performed using an FC500 CXP ﬂow
cytometer (Beckman Coulter, Fullerton, CA, USA). At least
20 000 events were acquired for each sample, cell debris were
gated out by forward and side scatter proﬁles. The antibodies
used were PE-conjugated anti-CD49f (0.5 mg for 106 cells in
100 mL volume) and Alexa Fluor 488 conjugated anti-CD61 (1 mg
for 106 cells in 100 mL volume) obtained from BioLegend,
SanDiego, CA, USA. At 80% conﬂuency H6O5 was detached
from culture plates using Accutase (Invitrogen), passed through a
40 mm nylon mesh (Fisher Scientiﬁc) to obtain single cells and
suspended in FACS buﬀer (PBS, 2% FBS) at 1  106 mL1 and
incubated with indicated antibodies for 30 minutes on ice. Cells
were washed thrice with FACS buﬀer prior to analysis. Cell
sorting was carried out on a FACSAria II cell sorter (Becton
Dickinson). Results were analysed using WinMDI 2.9 software.
In vitro clonogenic assay
H6O5 cells were detached from ECM coated plates and reseeded
in six-well tissue culture plates at a density of 500 cells per well in
complete medium. After 10 days, colonies were ﬁxed with 4%
paraformaldehyde and stained with 0.1% crystal violet. Colonies
with sizes greater than 0.5 mm in diameter were counted.
In vitro mammosphere–tumorsphere formation assay
H6O5 cells were detached from ECM coated plates and rinsed
with serum free media, plated in low attachment 12-well plates
(NUNC, Germany) at a density of 20 000 cells per mL in
serum-free DMEM/F12 medium (Invitrogen, CA, USA) supple-
mented with 20 ng mL1 epidermal growth factor (Sigma,
St Louis, MO, USA), 10 ng mL1 basic ﬁbroblast growth
factor (Sigma), 5 mg mL1 insulin (Sigma), B-27 supplement
(1 : 50 dilution, Invitrogen) and 0.4% bovine serum albumin
(Sigma). Cells were cultured under 5% CO2 at 37 1C for a week.
RNA extraction and quantitative real-time reverse
transcriptase PCR
Total RNA was extracted using an RNeasy mini puriﬁcation
kit (Qiagen), and subsequently reverse-transcribed with a
qScriptTM cDNA synthesis kit (Quanta Biosciences Inc.).
RT-qPCR was carried out for 45 cycles of PCR (95 1C for
15 s, 60 1C for 15 s and 72 1C for 30 s) with iQ5 SYBR Green
supermix (Biorad) using primers indicated in Table S2 (ESIw).
In a 25 mL total volume of reaction mixture, 200 nM of
both forward and reverse primers (Integrated DNA Techno-
logies, Inc.) and 1 mg mL1 of cDNA template at a ﬁnal
concentration were employed. Data analysis was performed
for triplicate measurements using a 2DDCT method for relative
quantiﬁcation41 and all samples were normalized to Gapdh
expression as the internal control.
Statistical analysis
All assays were performed in triplicates. Data are indicated as
mean  standard deviation. Comparisons between two groups
were done using paired student’s t-test. (*) p o 0.05 was
considered as signiﬁcant. Gene expression was normalized and
analyzed using a ‘pair wise ﬁxed reallocation randomization
test’42 on each sample and a value of po 0.05 was considered
as signiﬁcant.
Conclusions
Herein, we have demonstrated that TICs derived from Her2/
neu-induced mammary tumour cells show ﬂexibility in response
to various microenvironments. Diﬀerent ECM proteins can
inﬂuence the behaviour of cancer stem cells as evidenced from
the functional properties of the cells as well as their gene
expression pattern. Our results showed that Lam-I maintains
the majority of the TIC population and Fn induces an EMT-
like phenotype, whereas Coll-I triggers a diﬀerentiation pheno-
type. Furthermore, we conducted an additional experiment
with a well-studied human breast cancer cell model MCF-7.
This cell line has been shown to possess a side population of
cells with cancer stem cell phenotype identiﬁed with the
CD44highCD24low expression level when propagated under
suspension culture.1,43 We investigated the eﬀect of ECM proteins
on this human breast cancer cell line and our preliminary data
demonstrate similar changes in morphology followed by an
increase in the CD44highCD24low population, as observed with
H6O5 when cultured on laminin coated matrices in comparison
to the TCP control (Fig. S5, ESIw). Hence this result correlates to
our hypothesis that laminin maintains or in other words increases
the tumour-initiating cell population. The results of this work will
help us to determine speciﬁc cancer stem cell responses like lineage
maintenance, diﬀerentiation or other phenotypic transitions
through cell-matrix interactions, henceforth provide better under-
standing of the tumour microenvironment and thus help us design
suitable treatments.
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